Wylie Burke
#64,004
Most Influential Person Now
Researcher
Wylie Burke's AcademicInfluence.com Rankings
Wylie Burkemedical Degrees
Medical
#1951
World Rank
#2339
Historical Rank
#436
USA Rank
Public Health
#402
World Rank
#415
Historical Rank
#78
USA Rank
Epidemiology
#539
World Rank
#561
Historical Rank
#76
USA Rank
Wylie Burkephilosophy Degrees
Philosophy
#5234
World Rank
#7982
Historical Rank
#1398
USA Rank
Logic
#5399
World Rank
#6793
Historical Rank
#887
USA Rank
Download Badge
Medical Philosophy
Wylie Burke's Degrees
- Doctorate Medicine University of Washington
- Masters Public Health University of Washington
Why Is Wylie Burke Influential?
(Suggest an Edit or Addition)According to Wikipedia, Wylie Burke is a Professor Emerita and former Chair of the Department of Bioethics and Humanities at the University of Washington and a founding co-director of the Northwest-Alaska Pharmacogenomics Research Network, which partners with underserved populations in the Pacific Northwest and Alaska.
Wylie Burke's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography (2007) (2494)
- International network of cancer genome projects (2010) (1839)
- Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2 (1997) (939)
- American Cancer Society Guidelines for Breast Cancer Screening: Update 2003 (2003) (785)
- Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. (2006) (645)
- Recommendations for Follow-up Care of Individuals With an Inherited Predisposition to Cancer: I. Hereditary Nonpolyposis Colon Cancer (1997) (613)
- HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. (2001) (397)
- Actionable, pathogenic incidental findings in 1,000 participants' exomes. (2013) (359)
- Return of genomic results to research participants: the floor, the ceiling, and the choices in between. (2014) (336)
- Ethical and Practical Guidelines for Reporting Genetic Research Results to Study Participants: Updated Guidelines from a National Heart, Lung, and Blood Institute Working Group (2010) (324)
- Actionable exomic incidental findings in 6503 participants: challenges of variant classification (2015) (308)
- Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors (2011) (302)
- Hereditary hemochromatosis: gene discovery and its implications for population-based screening. (1998) (290)
- Recommendations for returning genomic incidental findings? We need to talk! (2013) (275)
- ASHG Statement* on Direct-to-Consumer Genetic Testing in the United States (2007) (270)
- An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons. (2008) (258)
- The complexities of predictive genetic testing (2001) (224)
- Genetic testing. (2002) (222)
- Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. (1994) (211)
- Primary care physicians' knowledge of and experience with pharmacogenetic testing (2012) (207)
- Personalized medicine in the era of genomics. (2007) (191)
- Genomic profiling to promote a healthy lifestyle: not ready for prime time (2003) (182)
- Genetic test evaluation: information needs of clinicians, policy makers, and the public. (2002) (182)
- Family history as a predictor of asthma risk. (2003) (177)
- Genomic research and wide data sharing: Views of prospective participants (2010) (173)
- Offering Individual Genetic Research Results: Context Matters (2010) (170)
- The path from genome-based research to population health: Development of an international public health genomics network (2006) (165)
- Breast cancer and hormone replacement therapy (1997) (147)
- Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. (2016) (143)
- Genetics and Public Health in the 21st Century (2000) (141)
- Newborn Screening Technology: Proceed With Caution (2006) (141)
- Next-generation sequencing in the clinic: are we ready? (2012) (130)
- Hereditary diffuse gastric cancer: association with lobular breast cancer (2007) (127)
- Trends in death associated with pediatric dental sedation and general anesthesia (2013) (126)
- Differential use of available genetic tests among primary care physicians in the United States: results of a national survey (2008) (123)
- Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network (2012) (123)
- National Institutes of Health State-of-the-Science Conference: Role of Active Surveillance in the Management of Men With Localized Prostate Cancer (2012) (121)
- Categorizing genetic tests to identify their ethical, legal, and social implications. (2001) (120)
- Glad You Asked: Participants' Opinions of Re-Consent for DbGap Data Submission (2010) (118)
- Iron Overload, Public Health, and Genetics: Evaluating the Evidence for Hemochromatosis Screening (1998) (118)
- National Institutes of Health State-of-the-Science Conference (2012) (113)
- Genetics education for primary-care providers (2002) (112)
- Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis. (2015) (110)
- Genomics as a probe for disease biology. (2003) (102)
- The cost-effectiveness of returning incidental findings from next-generation genomic sequencing (2014) (99)
- Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium (2013) (99)
- Extending the reach of public health genomics: What should be the agenda for public health in an era of genome-based and “personalized” medicine? (2010) (90)
- Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease (2003) (89)
- Return of results: Ethical and legal distinctions between research and clinical care (2014) (88)
- Contribution of different HFE genotypes to iron overload disease: a pooled analysis (2000) (85)
- Research Practice and Participant Preferences: The Growing Gulf (2011) (85)
- The FDA and genomic tests--getting regulation right. (2015) (84)
- A formal risk-benefit framework for genomic tests: Facilitating the appropriate translation of genomics into clinical practice (2010) (84)
- Genetics in Primary Care: A USA Faculty Development Initiative (2002) (83)
- Genetic counseling for women with an intermediate family history of breast cancer. (2000) (82)
- Predicting breast cancer screening intentions and behavior with emotion and cognition. (2003) (79)
- Return of incidental findings in genomic medicine: measuring what patients value—development of an instrument to measure preferences for information from next-generation testing (IMPRINT) (2013) (77)
- Application of population screening principles to genetic screening for adult-onset conditions. (2001) (76)
- Genetic Tests: Clinical Validity and Clinical Utility (2014) (76)
- Current priorities for public health practice in addressing the role of human genomics in improving population health. (2011) (74)
- The advent of the ‘unpatients’ (1996) (70)
- Gene expression profiling and breast cancer care: What are the potential benefits and policy implications? (2005) (69)
- Will genomics widen or help heal the schism between medicine and public health? (2007) (68)
- Large de novo DNA deletion in a patient with sporadic neurofibromatosis 1, mental retardation, and dysmorphism. (1992) (67)
- Genetic testing in primary care. (2004) (67)
- Genetic assessment of breast cancer risk in primary care practice (2009) (66)
- Researcher Perspectives on Disclosure of Incidental Findings in Genetic Research (2010) (65)
- Challenges in communicating genetics: A public health approach (2000) (64)
- Ethical issues arising from the participation of children in genetic research. (2006) (63)
- Managing incidental genomic findings: legal obligations of clinicians (2013) (63)
- Genomics, Health Disparities, and Missed Opportunities for the Nation's Research Agenda. (2017) (63)
- The Genomic Applications in Practice and Prevention Network (2009) (63)
- Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis. (1995) (63)
- Temporal order in yeast chromosome replication (1975) (63)
- If you build it, they will come: unintended future uses of organised health data collections (2016) (61)
- Ethical issues in identifying and recruiting participants for familial genetic research (2004) (61)
- The OHRP and SUPPORT. (2013) (61)
- Potential for genetics to promote public health: genetics research on smoking suggests caution about expectations. (2006) (61)
- Breast cancer risk counseling improves women's functioning. (2004) (61)
- Ensuring the appropriate use of genetic tests (2004) (60)
- Pharmacogenetic testing: not as simple as it seems (2008) (59)
- Exploring pathways to trust: a tribal perspective on data sharing (2014) (58)
- Proceedings from the 9th annual conference on the science of dissemination and implementation (2017) (57)
- Participation in Breast Cancer Genetic Counseling: The Influence of Educational Level, Ethnic Background, and Risk Perception (2001) (56)
- Public health impact of genetic tests at the end of the 20th century (2001) (54)
- Uncertainties in genetic testing for chronic disease. (1998) (54)
- Confronting real time ethical, legal, and social issues in the Electronic Medical Records and Genomics (eMERGE) Consortium (2010) (53)
- Genetic exceptionalism. Too much of a good thing? (2008) (52)
- Regulating Direct-to-Consumer Personal Genome Testing (2010) (52)
- Offering aggregate results to participants in genomic research: opportunities and challenges (2012) (51)
- Adding pharmacogenetics information to drug labels: lessons learned (2006) (50)
- Informed Consent in Genome-Scale Research: What Do Prospective Participants Think? (2012) (50)
- Pharmacogenomic testing to prevent aminoglycoside-induced hearing loss in cystic fibrosis patients: potential impact on clinical, patient, and economic outcomes (2007) (49)
- Mapping the Ethics of Translational Genomics: Situating Return of Results and Navigating the Research-Clinical Divide (2015) (49)
- Using pharmacogenetics to improve drug safety and efficacy. (2004) (48)
- An economic viewpoint on alternative strategies for identifying persons with hereditary nonpolyposis colorectal cancer (2003) (47)
- Misleading presentation of breast cancer in popular magazines. (2001) (46)
- REPLICATION OF SMALL CHROMOSOMAL DNAS IN YEAST (1980) (45)
- Cytochrome P450 Enzyme Polymorphism Frequency in Indigenous and Native American Populations: A Systematic Review (2008) (44)
- Design, implementation, and first-year outcomes of a value-based drug formulary. (2015) (42)
- Ethical Issues in Developing Pharmacogenetic Research Partnerships With American Indigenous Communities (2011) (42)
- Screening for hemochromatosis. A public health perspective. (1999) (41)
- Essential elements of personalized medicine. (2014) (40)
- Building Partnerships in Community-Based Participatory Research (2014) (39)
- Diverse Perceptions of the Informed Consent Process: Implications for the Recruitment and Participation of Diverse Communities in the National Children’s Study (2012) (39)
- Effects of web-based intervention on risk reduction behaviors in melanoma survivors (2015) (39)
- Educational Needs in Genetic Medicine: Primary Care Perspectives (2008) (38)
- Explaining the Black-White Disparity in Preterm Birth: A Consensus Statement From a Multi-Disciplinary Scientific Work Group Convened by the March of Dimes (2021) (38)
- Effects of risk counseling on interest in breast cancer genetic testing for lower risk women (2002) (38)
- Whole‐Genome Sequencing in Healthy People (2017) (38)
- Health System Implications of Direct-to-Consumer Personal Genome Testing (2010) (37)
- Risk, reward, and the double-edged sword: perspectives on pharmacogenetic research and clinical testing among Alaska Native people. (2013) (36)
- Closing the Gap between Knowledge and Clinical Application: Challenges for Genomic Translation (2015) (36)
- Ancillary risk information and pharmacogenetic tests: social and policy implications (2008) (36)
- Clinical Validity and Clinical Utility of Genetic Tests (2004) (36)
- Is there a duty to reinterpret genetic data? The ethical dimensions (2019) (35)
- What influences career choices among graduates of a primary care training program? (1998) (35)
- NIH State-of-the-Science Conference Statement: Role of active surveillance in the management of men with localized prostate cancer. (2011) (35)
- Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy: Design and Implementation of the DCM Precision Medicine Study (2017) (34)
- Effects of Individual and Family Functioning on Interest in Genetic Testing (2004) (34)
- The human genome at ten (2010) (34)
- Genetic risk in context: calculating the penetrance of BRCA1 and BRCA2 mutations. (2002) (34)
- Genetics researchers’ and IRB professionals’ attitudes toward genetic research review: a comparative analysis (2012) (33)
- Pharmacogenetic research in partnership with American Indian and Alaska Native communities. (2014) (33)
- Hypertension and the genetics of red cell membrane abnormalities. (1987) (33)
- Is Incidental Finding the Best Term? A Study of Patients’ Preferences (2016) (32)
- Implementing Precision Medicine: The Ethical Challenges. (2017) (32)
- Hemochromatosis: genetics helps to define a multifactorial disease (1998) (32)
- The rules remain the same for genomic medicine: The case against “reverse genetic exceptionalism” (2010) (30)
- Jewish identity and intentions to obtain breast cancer screening. (2003) (30)
- Does genomic risk information motivate people to change their behavior? (2009) (30)
- Handbook of professional ethics for psychologists : issues, questions, and controversies (2003) (30)
- Navigating the research–clinical interface in genomic medicine: analysis from the CSER Consortium (2017) (30)
- Waiving informed consent in newborn screening research: Balancing social value and respect (2008) (29)
- Clinical Genetic Testing for APOL1: Are we There Yet? (2017) (29)
- You Are Just Now Telling Us About This? African American Perspectives of Testing for Genetic Susceptibility to Kidney Disease. (2019) (28)
- Regulatory changes raise troubling questions for genomic testing (2014) (27)
- Values in Translation: How Asking the Right Questions Can Move Translational Science Toward Greater Health Impact (2012) (27)
- Pathways from Autism Spectrum Disorder (ASD) Diagnosis to Genetic Testing (2017) (27)
- Breast cancer risk communication: Assessment of primary care physicians by standardized patients (2009) (27)
- Ethics Rounds: Death After Pediatric Dental Anesthesia: An Avoidable Tragedy? (2017) (27)
- Population-Based Estimates of the Prevalence of Family History of Cancer among Women (2002) (27)
- Toward better governance of human genomic data (2021) (26)
- Community dissemination and genetic research: Moving beyond results reporting (2015) (26)
- Iron deficiency and iron overload: effects of diet and genes (2001) (26)
- Variant Interpretation for Dilated Cardiomyopathy (2020) (26)
- Primary-care physicians’ access to genetic specialists: an impediment to the routine use of genomic medicine? (2013) (26)
- Maternal perspectives on the return of genetic results: Context matters (2013) (25)
- Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice (2016) (25)
- Genetic screening. (2011) (25)
- Native Hawaiian Views on Biobanking (2014) (25)
- The translational potential of research on the ethical, legal, and social implications of genomics (2014) (24)
- Defining purpose: a key step in genetic test evaluation (2007) (24)
- Genetics as a tool to improve cancer outcomes: ethics and policy (2006) (23)
- Access and Management: Indigenous Perspectives on Genomic Data Sharing. (2019) (23)
- Translational Genomics: Seeking a Shared Vision of Benefit (2008) (23)
- Family History Assessment to Detect Increased Risk for Colorectal Cancer: Conceptual Considerations and a Preliminary Economic Analysis (2005) (23)
- From Leaky Pipeline to Irrigation System: Minority Education Through the Lens of Community-Based Participatory Research (2012) (23)
- Will Knowledge of Gene-Based Colorectal Cancer Disease Risk Influence Quality of Life and Screening Behavior? (2009) (23)
- Motivating factors for physician ordering of factor V Leiden genetic tests. (2009) (22)
- Population description and its role in the interpretation of genetic association (2010) (22)
- Taking Family History Seriously (2005) (22)
- The Feelings About genomiC Testing Results (FACToR) Questionnaire: Development and Preliminary Validation (2018) (22)
- Experiences of patients seeking to participate in variant of uncertain significance reclassification research (2018) (21)
- Long-term outcomes of the "Genetics in Primary Care" faculty development initiative. (2009) (21)
- Anticipating dissemination of cancer genomics in public health: A theoretical approach to psychosocial and behavioral challenges (2007) (21)
- Hereditary hemochromatosis: Perspectives of public health, medical genetics, and primary care (2003) (20)
- Genetics and public health (2009) (20)
- Comparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes. (2014) (20)
- P450 Pharmacogenetics in Indigenous North American Populations (2018) (20)
- Effects of counseling Ashkenazi Jewish women about breast cancer risk. (2006) (20)
- Informed Consent in Translational Genomics: Insufficient Without Trustworthy Governance (2018) (19)
- Pharmacogenomics in diverse practice settings: implementation beyond major metropolitan areas. (2015) (19)
- Hereditary haemochromatosis: a realistic approach to prevention of iron overload disease in the population. (2002) (19)
- Oncologists' opinions on genetic testing for breast and ovarian cancer (2001) (19)
- The Deceptive Appeal of Direct-to-Consumer Genetics (2016) (18)
- Achieving utility with family history: colorectal cancer risk. (2003) (18)
- Stakeholder Perspectives on a Risk-Benefit Framework for Genetic Testing (2010) (18)
- Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions (2019) (18)
- All in the family? Communication of cancer survivors with their families (2017) (18)
- Use of Factor V Leiden genetic testing in practice and impact on management (2009) (18)
- Genetic information: Special or not? Responses from focus groups with members of a health maintenance organization (2007) (18)
- Contributions of Public Health to Genetics Education for Health Care Professionals (2005) (17)
- Erratum: Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine (American Journal of Human Genetics (2016) 98(6) (1067–1076) (S0002929716301069) (10.1016/j.ajhg.2016.04.011)) (2016) (17)
- Patients' Choices for Return of Exome Sequencing Results to Relatives in the Event of Their Death (2015) (17)
- Deliberate deceit of family members: a challenge to providers of clinical genetics services. (2006) (16)
- Randomized trial of a web-based survivor intervention on melanoma prevention behaviors of first-degree relatives (2018) (16)
- Delivery of primary care to women (2007) (15)
- Duty to warn at-risk family members of genetic disease. (2009) (15)
- The effect of Mycoplasma contamination on the in vitro assay of pyruvate dehydrogenase activity in cultured fibroblasts. (1978) (15)
- Seeking Genomic Knowledge: The Case for Clinical Restraint. (2013) (15)
- Night shifts: Circadian biology for public health (2017) (15)
- Predictors of recruited melanoma families into a behavioral intervention project. (2012) (14)
- Familial Aggregation of Early-Onset Myocardial Infarction (2002) (14)
- Communication Among Melanoma Family Members (2017) (14)
- Identifying “ownership” through role descriptions to support implementing universal colorectal cancer tumor screening for Lynch Syndrome (2017) (14)
- Incorporating Principles and Practical Wisdom in Research Ethics Education: A Preliminary Study (2007) (13)
- Carnitine palmitoyltransferase 1A P479L and infant death: policy implications of emerging data (2017) (13)
- 'That's like chopping off a finger because you're afraid it might get broken': disease and illness in women's views of prophylactic mastectomy. (2005) (13)
- Ethical obligations and counseling challenges in cancer genetics. (2006) (13)
- Prevalence and Cumulative Risk of Familial Idiopathic Dilated Cardiomyopathy. (2022) (13)
- Patient safety in genomic medicine: an exploratory study (2016) (13)
- The Feelings About genomiC Testing Results (FACToR) Questionnaire: Development and Preliminary Validation. (2019) (12)
- Consent insufficient for data release (2019) (12)
- Systems medicine and the public's health (2011) (11)
- Responsible Research With Urban American Indians and Alaska Natives. (2018) (11)
- Achieving Justice in Genomic Translation: Re-Thinking the Pathway to Benefit (2011) (11)
- Implementation outcomes of a multiinstitutional web-based ethical, legal, and social implications genetics curriculum for primary care residents in three specialties (2011) (10)
- Changing the clinical management of hereditary hemochromatosis: translating screening and early case detection strategies into clinical practice. (2004) (10)
- Clinical decisions. Screening an asymptomatic person for genetic risk. (2014) (10)
- Incorporation of purine nucleosides in cultured fibroblasts from a patient with purine nucleoside phosphorylase deficiency and associated T‐cell immunodeficiency (1977) (10)
- Data Management in Health-Related Research Involving Indigenous Communities in the United States and Canada: A Scoping Review (2019) (10)
- Personalized Medicine and Tobacco-Related Health Disparities: Is There a Role for Genetics? (2011) (10)
- Beneficence, Clinical Urgency, and the Return of Individual Research Results to Relatives (2012) (9)
- Screening for hereditary hemochromatosis: are DNA-based tests the answer? (1999) (9)
- Improving recommendations for genomic medicine: building an evolutionary process from clinical practice advisory documents to guidelines (2019) (9)
- A reality check for personalized medicine (2010) (9)
- Benefits and Risks of Screening Mammography in Women With BRCA1 and BRCA2 Mutations-Reply (1997) (9)
- Genetics of Breast and Ovarian Cancer (1999) (8)
- Clinician-Stakeholders’ Perspectives on Using Patient Portals to Return Lynch Syndrome Screening Results (2018) (8)
- The Challenge of Genetic Variants of Uncertain Clinical Significance (2022) (8)
- Practice Implications of Expanded Genetic Testing in Oncology (2019) (8)
- Response—The Risks and Benefits of Re-Consent (2011) (7)
- Partnership with the Confederated Salish and Kootenai Tribes: Establishing an Advisory Committee for Pharmacogenetic Research (2016) (7)
- Clinical exome sequencing vs. usual care for hereditary colorectal cancer diagnosis: A pilot comparative effectiveness study. (2019) (7)
- ADDENDUM: Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors (2019) (7)
- Prenatal Pharmacogenomics: A promising area for research (2016) (7)
- Discordance in selected designee for return of genomic findings in the event of participant death and estate executor (2017) (7)
- Diagnosis, Education, and Care of Patients with APOL1-Associated Nephropathy: A Delphi Consensus and Systematic Review (2021) (7)
- Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. (2016) (7)
- Age of onset in Huntington's disease: lack of parental age effect. (1976) (7)
- Utility and Diversity: Challenges for Genomic Medicine. (2021) (6)
- Predictive and Precision Medicine with Genomic Data. (2019) (6)
- Perceptions of alcohol misuse among Alaska native health care system stakeholders: A qualitative exploration (2020) (6)
- Can Precision Medicine Reduce the Burden of Diabetes? (2019) (6)
- Partnership with the Confederated Salish and Kootenai Tribes: Establishing an Advisory Committee for Pharmacogenetic Research. (2016) (5)
- Standardizing return of participant results (2018) (5)
- WHAT DNA CAN AND CANNOT SAY: PERSPECTIVES OF IMMIGRANT FAMILIES ABOUT THE USE OF GENETIC TESTING IN IMMIGRATION. (2015) (5)
- Will the Real Hemochromatosis Please Stand Up? (1999) (5)
- Teaching with single nucleotide polymorphisms: Learning the right lessons (2011) (5)
- Bioethics of Genetic Testing for Hereditary Breast Cancer (2007) (5)
- Making Sense of the Genome Remains a Work in Progress. (2018) (5)
- Genetics of Colorectal Cancer for Clinical Practice. (1995) (5)
- Hypertension: some unanswered questions. (1985) (5)
- Precision medicine research with American Indian and Alaska Native communities: Results of a deliberative engagement with tribal leaders. (2021) (5)
- Avoiding the technological imperative: Criteria for genetic screening programs (2017) (5)
- Practical Ethics: Establishing a Pathway to Benefit for Complex Pharmacogenomic Tests (2011) (4)
- Breast carcinoma genetics from a primary care perspective (1997) (4)
- Clinical and public health implications of emerging genetic technologies. (2010) (4)
- Uninformed consent in nutrigenomic research (2017) (4)
- Public health strategies to prevent the complications of hemochromatosis (2009) (4)
- Patient goals, motivations, and attitudes in a patient‐driven variant reclassification study (2018) (4)
- Will the real hemochromatosis please stand up (1999) (4)
- Comprar Achieving Justice in Genomic Translation Re-Thinking the Pathway to Benefit | Susan Brown Trinidad | 9780195390384 | Oxford University Press (2011) (4)
- Re: On the use of familial aggregation in population-based case probands for calculating penetrance. (2003) (4)
- At the Research-Clinical Interface: Returning Individual Genetic Results to Research Participants. (2020) (4)
- Is there a way to reduce the inequity in variant interpretation on the basis of ancestry? (2022) (4)
- Genetic Research and Smoking Behavior—Reply (2007) (3)
- The Role of Family History in Personal Prevention Practices among US Women Physicians (2001) (3)
- Practicing Moral Medicine: Patient Care to Public Health (2006) (3)
- Genetics of Hypertension – An Overview (1991) (3)
- Precision medicine and health disparities: The case of pediatric acute lymphoblastic leukemia. (2019) (3)
- A call for accurate pharmacogenetic labeling: telling it like it is. (2014) (3)
- Management of women at high genetic risk of ovarian cancer (1999) (3)
- Looking for Trouble and Finding It (2015) (3)
- Red Cell Sodium-Lithium Countertransport in Hypertension (1984) (3)
- Molecular Genetics of Hypertension (1992) (3)
- The Precautionary Principle for Shift-Work Research and Decision-Making (2018) (3)
- Exploring relatives’ perceptions of participation, ethics, and communication in a patient‐driven study for hereditary cancer variant reclassification (2020) (3)
- Dietary and genetic influences on hemostasis in a Yup’ik Alaska Native population (2017) (3)
- Community crystal gazing (2016) (2)
- Preimplantation Genetic Testing for Genetic Kidney Disease: Addressing Moral Uncertainties and Access Inequity. (2020) (2)
- The aging cystic fibrosis patient: presentations and problems (1994) (2)
- "You Actually View Us as the Experts in Our Own System": Indigenous–Academic Community Partnership (2020) (2)
- Ethical Considerations in Precision Medicine and Genetic Testing in Internal Medicine Practice: A Position Paper From the American College of Physicians (2022) (2)
- Public health assessment of genetic predisposition to cancer (2009) (2)
- ERRATUM: Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium (2014) (2)
- Testing minors for breast cancer. (2007) (2)
- The Asthma Consultative Process: A Collaborative Approach to Integrating Genomics Into Public Health Practice (2005) (2)
- Ethical Issues in Genetic Epidemiology (2009) (2)
- ASHG Presidential Address: Who is under the umbrella--and why are we here? (2008) (2)
- Results to a Participant ’ s Family , Including After the Participant ’ s Death ? (2015) (2)
- Clinical Validity and Clinical Utility of Genetic Tests (2004) (2)
- Eugenics to medical genetics (2013) (1)
- Incentivizing Value In Managed Care Drug Formularies: Design, Implementation, And First-Year Outcomes Of A Value-Based Formulary (2014) (1)
- If you build it, they will come: unintended future uses of organised health data collections (2016) (1)
- Comment on: On the use of familial aggregation in population-based case probands for calculating penetrance. Authors' reply (2003) (1)
- Communicating Precision Medicine Research: Multidisciplinary Teams and Diverse Communities (2022) (1)
- Pharmacogenomics in Indigenous Populations (2019) (1)
- Breast cancer and breastfeeding (2003) (1)
- Tribal Deliberations about Precision Medicine Research: Addressing Diversity and Inequity in Democratic Deliberation Design and Evaluation (2022) (1)
- Night shifts: Circadian biology for public health. (2017) (1)
- Diabetes and HFE mutations: cause or coincidence? (2002) (1)
- Commentary to “My Identical Twin Sequenced Our Genome”: Cautionary Genomics (2017) (1)
- Stakeholder Perspectives on Returning Nonactionable Apolipoprotein L1 (APOL1) Genetic Results to African American Research Participants (2021) (1)
- Mammography American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to (2008) (1)
- PM4 AN EXPLORATION OF THE POTENTIAL CLINICAL BENEFITS AND RISKS OF CYP2D6 TESTING TO GUIDE TAMOXIFEN THERAPY IN BREAST CANCER (2009) (1)
- Practical Considerations for Reinterpretation of Individual Genetic Variants. (2023) (1)
- PERSONALIZED MEDICINE AND GENOMICS (2008) (1)
- The Trans Accountability Project: Community Engagement to Address Structural Marginalization and Health Inequities (2022) (1)
- Pathways from autism spectrum disorder diagnosis to genetic testing (2017) (1)
- Adult Genetic Screening: Are we ready for hemochromatosis? (2000) (0)
- Communal Coping as a Strategy to Enhance Family Engagement in Dilated Cardiomyopathy (2022) (0)
- All in the family? Communication of cancer survivors with their families (2017) (0)
- Genetic screening. (2003) (0)
- Industry, ethics, and general medicine (1997) (0)
- Correction to: Native Hawaiian Views on Biobanking (2019) (0)
- Cases in Precision Medicine: Is There an Obligation to Return Reinterpreted Genetic Results to Former Patients? (2023) (0)
- Response to Koeller et al. (2017) (0)
- Impact of Value-Based Benefits on Use of and Adherence to Drugs in 3 Disease Cohorts (2015) (0)
- Genetic testing [6] (multiple letters) (2003) (0)
- Authors’ Response Sedation Safety Has Many Perspectives, and the Discussion is Ongoing (2018) (0)
- Perspectives From Enrollees of a Large U.S. Health Care System on Informed Consent for Genetic Research (2016) (0)
- Family practice physicians and genetics education: a national survey assessing the sources, interests, and barriers of genetics education (2004) (0)
- Contents Vol. 5, 2002 (2002) (0)
- Erratum: Community crystal gazing (2016) (0)
- neurofibromatosis 1 ( NF 1 ) Growth in North American white children with Foundation (2000) (0)
- Response—Regulating Genetic Tests: Who Owns the Data? (2010) (0)
- Genetic Testing Beliefs Scales--Adapted (2012) (0)
- Banning Pens and Pads Misses the Main Point (2003) (0)
- Reviewer Acknowledgment (2013) (0)
- Breast cancer and breastfeeding [2] (multiple letters) (2003) (0)
- Process, issues, and ethics: Moving new science to new animals and new foods (1998) (0)
- Reviewer Acknowledgment (2009) (0)
- CASE2 INVENTING A TIERED FORMULARY BASED ON THE INCREMENTAL COST-EFFECTIVENESS OF DRUGS (2010) (0)
- 2021 McKusick Leadership Award: Learning from communities. (2022) (0)
- Correction to: Native Hawaiian Views on Biobanking (2019) (0)
- Experiences of patients seeking to participate in variant of uncertain significance reclassification research (2018) (0)
- Randomized trial of a web-based survivor intervention on melanoma prevention behaviors of first-degree relatives (2018) (0)
- Partnership with the Confederated Salish and Kootenai Tribes: Establishing an Advisory Committee for Pharmacogenetic Research (2016) (0)
- Hemochromatosis: Evidence for population-based testing for hemochromatosis (2000) (0)
- Values and Practices to Strengthen Genetic Research Partnerships with Indigenous Communities (2022) (0)
- Thanks to Reviewers2005 (2005) (0)
- Thanks to reviewers (1990) (0)
- Reviewer Acknowledgment (2005) (0)
- Improving recommendations for genomic medicine: building an evolutionary process from clinical practice advisory documents to guidelines (2019) (0)
- PCN12 HORIZON SCANNING TO SUPPORT PRIORITY-SETTING FOR PROSPECTIVE COMPARATIVE EFFECTIVENESS RESEARCH (CER) IN CANCER GENOMICS (2010) (0)
- Genomes in Context (2019) (0)
- Response to Strong (2015) (0)
- PCN74 WILL KNOWLEDGE OF GENETIC RISK FOR CANCER INFLUENCE QUALITY OF LIFE AND SCREENING BEHAVIOR? FINDINGS FROM A POPULATION-BASED STUDY (2008) (0)
- Native Hawaiian Views on Biobanking (2014) (0)
- OA07.06 Patient Knowledge and Expectations Related to Return of Genomic Results in the Lung-MAP (SWOG 1400) Biomarker-Driven Clinical Trial (2019) (0)
- Ethical Issues in Ecogenetics (2006) (0)
- Feelings About genomiC Testing Results Questionnaire (2020) (0)
- Getting ready for the tidal wave (2000) (0)
- 2.4 Genomics and public health (2009) (0)
- Teaching genetics in primary care through a transatlantic videoconference (2002) (0)
- Solidarity: A Missing Component of Research Ethics (2021) (0)
- Response to Faulkner et al. (2020) (0)
- Re: "Invited commentary: genes, environment, and hybrid vigor". (2010) (0)
- Is there a duty to reinterpret genetic data? The ethical dimensions (2019) (0)
- Response to Faulkner et al. (2020) (0)
- Measuring Attitudes About Alcohol Misuse and Dependence Among Alaska Native People Within a Tribal Health Care System (2022) (0)
- Breast cancer and breastfeeding. Authors' reply (2003) (0)
- Risk,Reward,andtheDouble-EdgedSword:Perspectives onPharmacogeneticResearchandClinicalTestingAmong AlaskaNativePeople (2013) (0)
- Response to Phillips et al. (2015) (0)
- Genetics, Health Care and Public Policy: Foreword (2007) (0)
- Obtaining informed consent from next-of-kin for research using genetic testing: legal vs. biological relatives (2003) (0)
- ERRATUM: Exonic duplication CNV of NDRG1 associated with autosomal-recessive HMSN-Lom/CMT4D (2014) (0)
- Genetic research and smoking behavior. Authors' reply (2007) (0)
- Making the choice: How women at risk for breast cancer feel about prophylactic mastectomy to reduce breast cancer risk if they were to have a positive BRCA genetic test (2011) (0)
- Effectiveness of the Family Heart Talk Communication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial (2023) (0)
- Book Review Building Genetic Medicine: Breast Cancer, Technology, and the Comparative Politics of Health Care (Inside Technology.) By Shobita Parthasarathy. 271 pp., illustrated. Cambridge, MA, MIT Press, 2007. $35. 978-0-262-16242-5 (2008) (0)
- Reviewer Acknowledgment (2008) (0)
- Subject Index Vol. 5, 2002 (2002) (0)
This paper list is powered by the following services:
Other Resources About Wylie Burke
What Schools Are Affiliated With Wylie Burke?
Wylie Burke is affiliated with the following schools:
